Hematologia
Tolerância à anemia normovolêmica
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (abre nova janela)
Fonte: N Engl J Med 1999;340(6):409-17.
Indexado: PubMed 9971864
DOI: 10.1056/NEJM199902113400601
https://www.ncbi.nlm.nih.gov/pubmed/9971864 (abre nova janela)
Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia. (abre nova janela)
Fonte: Transfus Med 2004;14(1):33-8.
Indexado: PubMed 15043591
DOI: 10.1111/j.0958-7578.2004.00477.x
https://www.ncbi.nlm.nih.gov/pubmed/15043591 (abre nova janela)
Transfusion strategies for patients in pediatric intensive care units. (abre nova janela)
Fonte: N Engl J Med 2007;356(16):1609-19.
Indexado: PubMed 17442904
DOI: 10.1056/NEJMoa066240
https://www.ncbi.nlm.nih.gov/pubmed/17442904 (abre nova janela)
Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (abre nova janela)
Fonte: Intensive Care Med 2013;39(3):445-53.
Indexado: PubMed 23184038
DOI: 10.1007/s00134-012-2757-z
https://www.ncbi.nlm.nih.gov/pubmed/23184038 (abre nova janela)
A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia. (abre nova janela)
Fonte: Blood 1999;93(9):3124-6.
Indexado: PubMed 10216111
https://www.ncbi.nlm.nih.gov/pubmed/10216111 (abre nova janela)
Anemia and blood transfusion in critically ill patients. (abre nova janela)
Fonte: JAMA 2002;288(12):1499-507.
Indexado: PubMed 12243637
https://www.ncbi.nlm.nih.gov/pubmed/12243637 (abre nova janela)